The largest database of trusted experimental protocols

Anti ly6g mab clone 1a8

Manufactured by BioLegend
Sourced in United States

Anti-Ly6G mAb (clone 1A8) is a monoclonal antibody that specifically binds to the Ly6G antigen. Ly6G is a cell surface marker expressed on neutrophils.

Automatically generated - may contain errors

2 protocols using anti ly6g mab clone 1a8

1

Multiparametric Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies used for evaluating splenocytes and TILs were: anti-CD3 mAb (clone 17A2, 100222); anti-CD4 mAb (clone GK1.5; 100406); anti-CD8 mAb (clone 53-6.7; 100712); anti-CD11b mAb (clone M1/70; 101228); anti-Ly6C mAb (clone HK1.4; 128006); anti-Ly6G mAb (clone 1A8; 127608); anti-CD16/CD32 mAb (clone 2.4G2; 101320) from Biolegend (San Diego; CA, USA), anti-CD44 mAb (clone IM7; 17-0441-82); anti-CD25 mAb (clone PC61.5; 45-0251-82) from (Thermo Fisher), anti-CD62L mAb (clone MEL-14; 553152; BD Biosciences; San Jose, CA, USA).
+ Open protocol
+ Expand
2

Neutrophil depletion and recruitment assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To deplete neutrophils in vivo, 0.25 mg depleting anti-Ly6G mAb (clone 1A8; BioLegend, San Diego, CA, USA) were injected i.p. 24 h before CLP procedure. For CXCR2 inhibition studies, the CXCR2 antagonist SB225002 (10 mg/kg, Cayman Chemical, Ann Arbor, MI, USA) were injected i.p. 1 h before CLP surgery (15 (link)). For the in vivo recruiting experiments, neutrophils from WT or Wip1 KO were labeled with PKH or CFSE in vitro and were injected i.v. together (4 × 106: 4 × 106) into neutrophil-depleted WT-recipient mice after CLP induction. PKH or CFSE-labeled neutrophils from WT or Wip1 KO donors were quantified in recipient peritoneal cavity 3 h after CLP by flow cytometry (Aria II; BD).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!